Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

M&A

Set Alert for MandA

Triveritas and Cyton come together under one group as part of acquisition

Germany's knoell group has stepped up its abilities in the veterinary contract research organization (CRO) space by purchasing UK firm Triveritas.

Europe M&A

Elanco prepares sale of European pet wormer rights to Vetoquinol

Elanco has moved a step closer to completing its acquisition of Bayer Animal Health by agreeing its third divestment deal to satisfy anti-trust regulators.

Europe Elanco

Zoetis continues vet reference lab acquisition trail with Ethos deal

Zoetis has made its third recent purchase in the veterinary reference laboratory space with the capture of Ethos Diagnostic Science.

Zoetis Diagnostics

Elanco secures all funds for Bayer transaction

Elanco has obtained all the funding needed to close the acquisition of Bayer Animal Health.

Elanco Bayer Animal Health

White Dog Labs to acquire production plant, negotiating MiruTyton off-take

US biotechnology start-up White Dog Labs (WDL) is set to acquire a new production plant in Minnesota.

Operations M&A

Elanco increases size of common stock offering

Elanco is offering a higher amount of common stock to fund a portion of its acquisition of Bayer Animal Health.

Bayer Animal Health Elanco

Darling Ingredients acquires insect feed firm

Texas-based Darling Ingredients has purchased a 50% joint venture interest in EnviroFlight – an insect feed company – to increase its stake to 100%.

M&A Deals

Elanco to make mixed offering to fund Bayer acquisition

Elanco will make public offerings of common stock and tangible equity units to help support its purchase of Bayer Animal Health.

Bayer Animal Health Elanco

Patterson could turn to acquisitions as business stabilizes

Patterson Companies could build on its animal health distribution business with acquisitions, according to the group's chief executive.

Patterson Companies M&A

Jeff Simmons sheds more light on next divestments for Elanco/Bayer deal

The next divestments from Elanco's ongoing acquisition of Bayer Animal Health could focus on the latter's portfolio.

Elanco Bayer Animal Health

Covetrus divests scil animal care to Heska, latter expects $200m sales boost

Covetrus is set to sell its scil animal care business to diagnostics specialist Heska for $125 million. 

Heska Diagnostics

Elanco set for minor growth in 2020 as firm begins evolution, agrees Capstar divestment

Elanco is expecting small full-year growth for 2019 and 2020, as the company turns its attention to building a foundation as an "omni-channel leader". 

Elanco Operations
UsernamePublicRestriction

Register